Anthera Halts Drug Trial By: MarketMinute.com Stock News March 12, 2012 at 17:21 PM EDT Anthera Pharmaceuticals Inc. (Nasdaq: ANTH) stopped a late stage clinical trial of its cardiovascular disease treatment varespladib because the drug was ineffective. Shares of the biopharmaceutical plummeted $2.86 to close at $3.56.